Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2728 results

Sort By:

A Study of Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)

Study ID: NCT05793567
Start Date: 2026-08
End Date: 2027-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

52

Intervention / Treatment

Coronary angiogram with coronary reactivity testing (CRT)

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer

Study ID: NCT06196671
Start Date: 2026-12-01
End Date: 2028-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

H101

Camrelizumab

Sponsor

Fudan University

Source: clinicaltrials.gov

Share:
Add to list

A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults

Study ID: NCT07047521
Start Date: 2025-11-17
End Date: 2027-07-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

496

Intervention / Treatment

Tetravalent Dengue Vaccine (TDV)

Sponsor

Takeda

Source: clinicaltrials.gov

Share:
Add to list

Utilizing Carbon Dioxide for Assessing Coronary Blood Flow in Subjects With Coronary Artery Disease

Study ID: NCT06253884
Start Date: 2026-01-10
End Date: 2027-07-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

RespirAct

Sponsor

Indiana University

Source: clinicaltrials.gov

Share:
Add to list

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

Study ID: NCT07091019
Start Date: 2025-11-15
End Date: 2033-05-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

TKIs

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Left Atrial Strain and Cryptogenic Stroke

Study ID: NCT07224178
Start Date: 2025-12-01
End Date: 2027-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

900

Intervention / Treatment
Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list

Testing the SurVaxM Vaccine for Lung Cancer Prevention

Study ID: NCT07169617
Start Date: 2026-02-25
End Date: 2027-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Biospecimen Collection

Montanide ISA 51 VG

Administration Questionnaire

Sargramostim

SVN53-67/M57-KLH Peptide Vaccine

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency

Study ID: NCT07129759
Start Date: 2026-09
End Date: 2030-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

150

Intervention / Treatment

LUM-201

Sponsor

Lumos Pharma

Source: clinicaltrials.gov

Share:
Add to list

Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment

Study ID: NCT07160686
Start Date: 2026-03-02
End Date: 2030-03-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1456

Intervention / Treatment

Apixaban

Placebo

Sponsor

University of Birmingham

Source: clinicaltrials.gov

Share:
Add to list

The Efficacy of Tooth Mouse, SFD and NaF in Caries Activity in Root Caries. A Randomized Clinical Trial

Study ID: NCT05765058
Start Date: 2026-02-01
End Date: 2027-06-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

136

Intervention / Treatment

Group A

Group B

Group C

Group D

Sponsor

University of Bern

Source: clinicaltrials.gov

Share:
Add to list